1. Home
  2. IRON vs NHC Comparison

IRON vs NHC Comparison

Compare IRON & NHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Disc Medicine Inc.

IRON

Disc Medicine Inc.

N/A

Current Price

$63.61

Market Cap

3.1B

Sector

Health Care

ML Signal

N/A

Logo National HealthCare Corporation

NHC

National HealthCare Corporation

N/A

Current Price

$223.35

Market Cap

3.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
IRON
NHC
Founded
2017
1971
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Hospital/Nursing Management
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
3.5B
IPO Year
2020
1997

Fundamental Metrics

Financial Performance
Metric
IRON
NHC
Price
$63.61
$223.35
Analyst Decision
Strong Buy
Analyst Count
13
0
Target Price
★ $103.17
N/A
AVG Volume (30 Days)
★ 444.2K
60.1K
Earning Date
11-05-2026
11-06-2026
Dividend Yield
N/A
★ 1.22%
EPS Growth
N/A
★ 17.46
EPS
N/A
★ 4.82
Revenue
N/A
★ $1,517,781,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$46.41
Revenue Growth
N/A
★ 16.09
52 Week Low
$40.00
$116.42
52 Week High
$99.50
$239.29

Technical Indicators

Market Signals
Indicator
IRON
NHC
Relative Strength Index (RSI) 31.11 47.09
Support Level $65.04 $211.74
Resistance Level $72.68 $231.67
Average True Range (ATR) 2.42 5.31
MACD -0.21 -0.42
Stochastic Oscillator 22.75 17.67

Price Performance

Historical Comparison
IRON
NHC

About IRON Disc Medicine Inc.

Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs), including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.

About NHC National HealthCare Corporation

National Healthcare Corp provides long-term care facilities. Its principal business includes operating skilled nursing facilities, assisted living facilities, independent living facilities, and home care programs. The company's activities include providing sub-acute and post-acute skilled nursing care, intermediate nursing care, rehabilitative care, memory and Alzheimer's care, senior living services, and home health care services. In addition, the company also provides management services, accounting, and financial services, as well as insurance services to third-party operators of healthcare facilities. Its reportable segments include Inpatient services and Home care and hospice services. The majority of revenue is derived from the Inpatient services segment.

Share on Social Networks: